Open AccessThe Prescription of Anticraving Medication and its Economic Consequences
Author(s) -
Rüdiger Holzbach,
Gunnar Stammen,
Ute Kirchhof,
Norbert Scherbaum
Publication year - 2019
Publication title -
european addiction research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.862
H-Index - 54
eISSN - 1421-9891
pISSN - 1022-6877
DOI - 10.1159/000500521
Subject(s) - medicine , medical prescription , emergency medicine , inpatient care , addiction , psychiatry , health care , pediatrics , pharmacology , economics , economic growth
According to recent studies, only a small proportion of alcoholics in the system for addiction treatment receive expedited treatment [Rehm et al.: Sucht 2014;60:93-105] and that those who are untreated are at risk of harmful and dependent alcohol consumption. This is associated with significantly negative effects on morbidity, mortality, and quality of life [Kraus et al.: Sucht 2010;56:337-347]. As a result, not only individuals and their environment suffer but there is also a health economic impact.